MARGINAL ZONE LYMPHOMA(MZL)
Clinical trials for MARGINAL ZONE LYMPHOMA(MZL) explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA(MZL) trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA(MZL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to wipe out lymphoma without prior treatment
Disease control OngoingThis study tests a combination of three drugs (orelabrutinib, zuberitamab, and chemotherapy) in 65 adults with untreated marginal zone lymphoma, a slow-growing blood cancer. The goal is to see if the treatment can make all signs of cancer disappear and keep it away for at least 2…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
Promising new combo targets rare eye cancer in early trial
Disease control OngoingThis study tests a new drug (orelabrutinib) combined with either low-dose radiation or another drug (rituximab) for a rare type of eye lymphoma called ocular adnexal MALT lymphoma. The goal is to see how well the treatment shrinks or eliminates the cancer. The trial includes 39 a…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 08:24 UTC
-
New antibody drug shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests an experimental drug called epcoritamab (GEN3013) in people with several types of B-cell lymphoma that have relapsed (come back) or are refractory (did not respond to prior treatment). The main goals are to find the safest and most effective dose, monitor side ef…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Is 'Watch and Wait' really 'Worry and Wait'? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how the 'watch and wait' approach affects the quality of life of people with slow-growing lymphomas. Researchers want to know if waiting without treatment causes anxiety or worry. About 250 Korean adults with these cancers will fill out questionnaires to measu…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:20 UTC